INTU vs ORMP
Intuit Inc (INTU) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the INTU and ORMP stock pages for the full models.
Not investment advice.